Quantum Hi-Tech (China) Biological Competitors and Similar CompaniesClear all
Quantum Hi-Tech (China) Biological's competitors and similar companies include Moderna, Pfizer, Fortrea and Novartis.
 Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ||
Founding Date | Founding Date 2000 | Founding Date 2010 | Founding Date 1849 | Founding Date 2023 | Founding Date 1996 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Guang Zhou Shi, CN HQ | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | |
Employees | Employees 1,814 | Employees 5,8004% increase | Employees 81,0008% decrease | Employees 19,000 | Employees 75,883 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 21.2 b | Valuation ($) 163.9 b | Valuation ($) 1.6 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥1.1b (FY, 2025) | Revenue (est.) $1.9b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $2.7b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) |
Cost of goods | Cost of goods ¥810m (FY, 2025) | Cost of goods $868m (FY, 2025) | Cost of goods $16.1b (FY, 2025) | Cost of goods N/A | Cost of goods $8.4b (FY, 2025) |
Gross profit | Gross profit ¥320.9m (FY, 2025) | Gross profit $1.1b (FY, 2025) | Gross profit $46.5b (FY, 2025) | Gross profit N/A | Gross profit $49.8b (FY, 2025) |
Net income | Net income ¥13.6m (FY, 2025) | Net income ($2.8b) (FY, 2025) | Net income $7.8b (FY, 2025) | Net income ($986.2m) (FY, 2025) | Net income $14b (FY, 2025) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries N/A | Countries 200 (FY, 2024) | Countries 90 (Jul, 2023) | Countries N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products 5 (FY, 2024) | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.8b | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 6.5m |
For sources of this data, please see the company profile
View Company Profiles
Moderna
HQ
Cambridge, US
Employees
5,800↑ 4% increase
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyFortrea
HQ
Durham, US
Employees
19,000
Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO).
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company